Capecitabine in advanced gastric cancer.

about

Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer

P2860

Q33918145-B62420D7-5759-4235-ADE3-5CB4C38BE694

P2860

Capecitabine in advanced gastric cancer.

Item

http://www.wikidata.org/entity/Q36979346

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Capecitabine in advanced gastric cancer.

@en

type

Item

label

Capecitabine in advanced gastric cancer.

@en

prefLabel

Capecitabine in advanced gastric cancer.

@en

P1476

Capecitabine in advanced gastric cancer.

@en

P2093

Alicia Okines

http://www.w3.org/2001/XMLSchema#string

Ian Chau

http://www.w3.org/2001/XMLSchema#string

P2860

Design of a novel oral fluoropyrimidine carbamate, capecitabine, which generates 5-fluorouracil selectively in tumours by enzymes concentrated in human liver and cancer tissue.

Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Extended safety and efficacy data on S-1 plus cisplatin in patients with untreated, advanced gastric carcinoma in a multicenter phase II study.

Prospective randomized trial comparing mitomycin, cisplatin, and protracted venous-infusion fluorouracil (PVI 5-FU) With epirubicin, cisplatin, and PVI 5-FU in advanced esophagogastric cancer.

A phase I and pharmacokinetic study of capecitabine in combination with epirubicin and cisplatin in patients with inoperable oesophago-gastric adenocarcinoma.

Phase II study of capecitabine plus cisplatin as first-line chemotherapy in advanced gastric cancer.

Phase II study of a 4-week capecitabine regimen in advanced or recurrent gastric cancer.

Capecitabine: preclinical pharmacology studies.

The modulated oral fluoropyrimidine prodrug S-1, and its use in gastrointestinal cancer and other solid tumors.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

P304

2851-2861

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.8.16.2851

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David Cunningham

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17956204

http://www.w3.org/2001/XMLSchema#string

Capecitabine in advanced gastric cancer.

about

P2860

P2860

Capecitabine in advanced gastric cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698